Emerging treatment strategies for COVID-19 infection
M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …
Reducing aerosol-related risk of transmission in the era of COVID-19: an interim guidance endorsed by the International Society of Aerosols in Medicine
National and international guidelines recommend droplet/airborne transmission and contact
precautions for those caring for coronavirus disease 2019 (COVID-19) patients in …
precautions for those caring for coronavirus disease 2019 (COVID-19) patients in …
Transmission of pathogen-laden expiratory droplets in a coach bus
Droplet dispersion carrying viruses/bacteria in enclosed/crowded buses may induce
transmissions of respiratory infectious diseases, but the influencing mechanisms have been …
transmissions of respiratory infectious diseases, but the influencing mechanisms have been …
[HTML][HTML] Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol
MT Neary, LM Mulder, PS Kowalski… - Journal of Controlled …, 2024 - Elsevier
In the past decade RNA-based therapies such as small interfering RNA (siRNA) and
messenger RNA (mRNA) have emerged as new and ground-breaking therapeutic agents for …
messenger RNA (mRNA) have emerged as new and ground-breaking therapeutic agents for …
Practical strategies to reduce nosocomial transmission to healthcare professionals providing respiratory care to patients with COVID-19
Abstract Coronavirus disease (COVID-19) is an emerging viral infection that is rapidly
spreading across the globe. SARS-CoV-2 belongs to the same coronavirus class that …
spreading across the globe. SARS-CoV-2 belongs to the same coronavirus class that …
Advances in pulmonary drug delivery
A Yıldız-Peköz, C Ehrhardt - Pharmaceutics, 2020 - mdpi.com
Pulmonary drug delivery represents an attractive, non-invasive administration option. In
addition to locally acting drugs, molecules that are intended to produce systemic effects can …
addition to locally acting drugs, molecules that are intended to produce systemic effects can …
Guideline for the management of COVID-19 patients during hospital admission in a non-intensive care setting
K Nielsen Jeschke, B Bonnesen… - European Clinical …, 2020 - Taylor & Francis
ABSTRACT Introduction Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
has presented health-care systems worldwide with novel challenges and experiences and …
has presented health-care systems worldwide with novel challenges and experiences and …
Nebuliser type influences both patient-derived bioaerosol emissions and ventilation parameters during mechanical ventilation
M Joyce, JA McGrath, M Mac Giolla Eain, A O'Sullivan… - Pharmaceutics, 2021 - mdpi.com
COVID-19 may lead to serious respiratory complications which may necessitate ventilatory
support. There is concern surrounding potential release of patient-derived bioaerosol during …
support. There is concern surrounding potential release of patient-derived bioaerosol during …
Investigation of fugitive aerosols released into the environment during high-flow therapy
JA McGrath, C O'Toole, G Bennett, M Joyce, MA Byrne… - Pharmaceutics, 2019 - mdpi.com
Background: Nebulised medical aerosols are designed to deliver drugs to the lungs to aid in
the treatment of respiratory diseases. However, an unintended consequence is the potential …
the treatment of respiratory diseases. However, an unintended consequence is the potential …
Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects
Inflammatory lung diseases related morbidity and mortality impose a significant financial
burden. Inflammation is a hallmark of many diseases of the respiratory system which is …
burden. Inflammation is a hallmark of many diseases of the respiratory system which is …